Abbvie (ABBV) Fundamental Analysis: Revenue, Earnings & Valuation

6.89 / 10

Outperform

Fundamentally, AbbVie scores 6.9/10, rated Outperform. Strengths include a low cost‑of‑sales ratio (29.76%) and solid interest coverage (3.51×), however, operating‑revenue growth is modest at 8.57% YoY, tempering the otherwise optimistic outlook.

Analysis Checks(9/10)

Total operating revenue (YoY growth rate %)

Value8.57

Score1/3

Weight-2.82%

1M Return-1.58%

Days sales outstanding

Value69.19

Score2/3

Weight-2.65%

1M Return-1.54%

Profit-MV

Value-0.36

Score2/3

Weight9.09%

1M Return4.33%

Net income-Revenue

Value0.28

Score3/3

Weight21.12%

1M Return7.98%

PB-ROE

Value1.95

Score2/3

Weight13.45%

1M Return5.86%

Cash-UP

Value-0.13

Score3/3

Weight21.69%

1M Return7.32%

Interest coverage ratio (EBIT / Interest expense) (%)

Value3.51

Score2/3

Weight-2.47%

1M Return-1.40%

Cost of sales ratio (%)

Value29.76

Score3/3

Weight2.01%

1M Return0.98%

Asset-MV

Value-0.55

Score3/3

Weight31.58%

1M Return11.95%

Cash-MV

Value-0.01

Score2/3

Weight9.00%

1M Return4.33%

Is ABBV fundamentally strong?

ABBV scores 6.89/10 on fundamentals and holds a Discounted valuation at present. Backed by its 6214.71% ROE, 6.92% net margin, 88.36 P/E ratio, -115.68 P/B ratio, and -1.25% earnings growth, these metrics solidify its Outperform investment rating.